63 Risk factors: a systematic review 2 73. Barclay NL, Gregory AM: Quantitative genetic research on sleep: a review of normal sleep, sleep disturbances and associated emotional, behavioural, and health-related difficulties. Sleep Med Rev 17:29-40, 2013 74. Byrne EM: The relationship between insomnia and complex diseases-insights from genetic data. Genome Medicine 11, 2019 75. Siddiq A, Lepretre F, Hercberg S, et al: A synonymous coding polymorphism in the alpha2Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians. Diabetes 54:2477-81, 2005 76. Vrooman LM, Stevenson KE, Supko JG, et al: Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study-DanaFarber Cancer Institute ALL Consortium Protocol 00-01. Journal of Clinical Oncology 31:12021210, 2013 77. Stock W, Luger SM, Advani AS, et al: A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403. Blood 133:1548-1559, 2019 78. Larsen EC, Devidas M, Chen S, et al: Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232. J Clin Oncol 34:2380-8, 2016 79. Engelen V, Haverman L, Koopman H, et al: Development and implementation of a patient reported outcome intervention (QLIC-ON PROfile) in clinical paediatric oncology practice. Patient Educ Couns 81:235-44, 2010 80. van Kooten J, van Litsenburg RRL, Yoder WR, et al: Validation of the PROMIS Sleep Disturbance and Sleep-Related Impairment item banks in Dutch adolescents. Qual Life Res 27:1911-1920, 2018 81. Ducore JM, Waller DA, Emslie G, et al: Acute psychosis complicating induction therapy for acute lymphoblastic leukemia. J Pediatr 103:477-80, 1983 82. Hechtman L, Russell RC, Young LJ: Psychosis in a boy with ADHD treated with stimulants and acute lymphocytic leukemia treated with chemotherapy and steroids. Neuropsychiatry 3:17-21, 2013 83. Kramer TM, Cottingham EM: Risperidone in the treatment of steroid-induced psychosis. J Child Adolesc Psychopharmacol 9:315-6, 1999 84. Samsel C, Muriel AC: Risk factors and treatment for steroid-related mood and behavior symptoms in preschool children with leukemia: A case series. Pediatr Blood Cancer 64:343-345, 2017 85. Tutkunkardas MD, Mukaddes NM: Drug induced mania in a boy with high functioning autism. Psychopharmacol Bull 43:82-5, 2010 86. Watanabe TK, Sylvester CE, Manaligod JM: Mania or panic associated with dexamethasone chemotherapy in adolescents. J Adolesc Health 15:345-7, 1994 87. Cassidy C, Sahay S, McNicholas F: Steroid-Induced Mania: A Case Report. Ir J Psychol Med 29:194195, 2012 88. Ingram DG, Hagemann TM: Promethazine treatment of steroid-induced psychosis in a child. Ann Pharmacother 37:1036-9, 2003 89. Sutor B, Wells LA, Rummans TA: Steroid-induced depressive psychosis responsive to electroconvulsive therapy. Convuls Ther 12:104-7, 1996 90. Ularntinon S, Tzuang D, Dahl G, et al: Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone. Pediatrics 125:e1241-5, 2010
RkJQdWJsaXNoZXIy MTk4NDMw